Search
Browse
Table of Contents
- Antidepressants
Selective Serotonin Reuptake Inhibitors (SSRI)- Norepinephrine Dopamine Reuptake Inhibitor (NDRI)
- Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
- Serotonin-2 Antagonists/Reuptake Inhibitors (SARI)
- Noradrenergic/Specific Serotonergic Antidepressants (NaSSA)
- Vilazodone
- Nonselective Cyclic Antidepressants
- Monoamine Oxidase Inhibitors
- Reversible Inhibitor of MAO-A (RIMA)
- Irreversible Monoamine Oxidase Inhibitors
- Monoamine Oxidase B Inhibitor
- Effects of Antidepressants on Neurotransmitters/Receptors
- Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors
- Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses
- Antidepressant Doses and Pharmacokinetics
- Switching Antidepressants
- Antidepressant Augmentation Strategies
- Electroconvulsive Therapy (ECT)
- Bright Light Therapy (BLT)
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- Antipsychotics
- “Second-Generation” Antipsychotics/SGAs
- “Third-Generation” Antipsychotic/TGA
- “First-Generation” Antipsychotics/FGAs
- Effects of Antipsychotics on Neurotransmitters/Receptors
- Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptors
- Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses
- Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections)
- Comparison of Long-Acting IM Antipsychotics
- Extrapyramidal Adverse Effects of Antipsychotics
- Switching Antipsychotics
- Antipsychotic Augmentation Strategies
- Agents for Treating Extrapyramidal Side Effects
- Anxiolytic (Antianxiety) Agents
- Hypnotics/Sedatives
- Mood Stabilizers
- Drugs for ADHD
- Drugs for Treatment of Dementia
- Sex-Drive Depressants
- Drugs of Abuse
- Treatment of Substance Use Disorders
- Unapproved Treatments of Psychiatric Disorders
- Herbal and “Natural” Products
- Suggested Resources for Information Regarding Drug Use in Pregnancy and Effects on Breast Milk
- Patient Information Sheets
- Patient Information on SSRI Antidepressants
- Patient Information on Bupropion
- Patient Information on SNRI Antidepressants
- Patient Information on SARI Antidepressants
- Patient Information on Mirtazapine
- Patient Information on Cyclic Antidepressants
- Patient Information on Moclobemide
- Patient Information on MAOI Antidepressants
- Patient Information on Transdermal Selegiline
- Patient Information on Electroconvulsive Therapy (ECT)
- Patient Information on Bright Light Therapy (BLT)
- Patient Information on Repetitive Transcranial Magnetic Stimulation (rTMS)
- Patient Information on Antipsychotic Drugs
- Patient Information on Clozapine
- Patient Information on Antiparkinsonian Agents for Treating Extrapyramidal Side Effects
- Patient Information on Benzodiazepine Antianxiety Drugs (Anxiolytics)
- Patient Information on Buspirone
- Patient Information on Hypnotics /Sedatives
- Patient Information on L-Tryptophan
- Patient Information on Lithium
- Patient Information on Anticonvulsant Mood Stabilizers
- Patient Information on Psychostimulants
- Patient Information on Atomoxetine
- Patient Information on Clonidine
- Patient Information on Drugs for Treatment of Dementia
- Patient Information on Sex-Drive Depressants
- Patient Information on Disulfiram
- Patient Information on Acamprosate
- Patient Information on Naltrexone
- Patient Information on Methadone
- Patient Information on Buprenorphine
- Glossary
© 2012 Hogrefe Publishing | Copyright Statement | Privacy Statement | About the Authors | Disclaimer | Terms of Use | FAQ | Contact